drug · vaccine component
patient view →SurVaxM
Phase 2updated 2mo agoby MimiVax LLC🔗 ChEMBL
Phase 2community read0 votes
Vaccine component drug with a maximum clinical stage of Phase 2 (across all indications), with 4 investigational indications.
targets
Baculoviral IAP repeat-containing protein 5Hemocyanin 1
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that